Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Comparison of clinical effects and pharmacokinetics of once-daily Uniphyl and twice-daily Theo-Dur in asthmatic patients.

Fairshter RD, Bhola R, Thomas R, Wilson AF, Hyatt J, Snapp S, Cummins L.

Am J Med. 1985 Dec 20;79(6A):48-53.

PMID:
4083298
2.

Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.

Rivington RN, Calcutt L, Hodder RV, Stewart JH, Aitken TL.

Am J Med. 1988 Jul 29;85(1B):48-53.

PMID:
3041826
3.

Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.

Ferrari M, Olivieri M, Lampronti G, Bonazza L, Biasin C, Nacci P, Talamini G, Lo Cascio V.

Thorax. 1997 Nov;52(11):969-74.

5.
6.

Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.

González MA, Kisicki J, Straughn AB.

Clin Ther. 1994 Jul-Aug;16(4):686-92.

PMID:
7982257
7.

Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).

Oosterhuis B, Brannan MD, Groen H, Peeters PA, Hempenius J, Radwanski E, Nomeir AA, Affrime MB, Jonkman JH.

Ann Allergy Asthma Immunol. 1995 Aug;75(2):157-61.

PMID:
7648380
8.

Once-a-day dosing with theophylline: a comparison of four sustained-release products.

Minotti DA, Altman LC, Ayars GH, Popick FR, Benn VJ.

Ann Allergy. 1992 Jun;68(6):500-6.

PMID:
1610026
9.

Comparison of morning versus evening dosing with a new once-daily oral theophylline formulation.

Rivington RN, Calcutt L, Child S, MacLeod JP, Hodder RV, Stewart JH.

Am J Med. 1985 Dec 20;79(6A):67-72.

PMID:
4083303
10.

Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.

Arkinstall WW, Atkins ME, Harrison D, Stewart JH.

Am Rev Respir Dis. 1987 Feb;135(2):316-21.

PMID:
3813191
11.

Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.

Williams PE, Alwazir YA, Routledge PA, Campbell IA.

Br J Clin Pharmacol. 1986 Oct;22(4):383-7.

12.
13.
14.

Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?

Bierman CW, Pierson WE, Shapiro GG, Furukawa CT.

Am J Med. 1988 Jul 29;85(1B):17-20.

PMID:
3041822
15.

A pharmacokinetic study of the recommended dosing schedules of Theo-Dur and Uniphylline.

Purkiss R, Cope A, Edwards C.

Allergy. 1984 Nov;39(8):634-8.

PMID:
6528959
17.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
19.

Conversion from intravenous to oral dosing using sustained-release theophylline tablets.

Stein GE, Haughey DB, Ross RJ, Vakoutis J.

Drug Intell Clin Pharm. 1982 Oct;16(10):772-4.

PMID:
7140514
20.

[24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].

D'Alonzo GE, Smolensky MH, Feldman S, Gianotti LA, Emerson MB, Staudinger HW, Sauter R, Steinijans VW.

Pneumologie. 1991 Nov;45 Suppl 4:834-41. German.

PMID:
1812476
Items per page

Supplemental Content

Support Center